VeriChip Corporation (the ๏ฟฝCompany๏ฟฝ) (NASDAQ: CHIP), a provider of radio frequency identification (RFID) systems for healthcare and patient-related needs, today announced that its personal health record used in conjunction with its VeriMed Health Link system will be accessible through Microsoft๏ฟฝ HealthVault๏ฟฝ, an online platform designed to put consumers in control of their health information. Through this agreement, Health Link members will have the ability to open free HealthVault accounts and input, store, view and interact with their health data. Further, the data within Health Link members๏ฟฝ existing accounts will be directly accessible through their HealthVault accounts. Scott R. Silverman, Chairman of the Company, said, ๏ฟฝVeriChip๏ฟฝs strategic alliance with Microsoft provides additional benefits to our members by enabling them to seamlessly store all of their personal health records on HealthVault๏ฟฝs robust, security-enhanced website. Furthermore, as an approved HeathVault solution provider, this agreement gives us added visibility among HealthVault๏ฟฝs member base. For those who have chosen our tamper-proof, safe, 'always on' link to their personal health information, we believe this relationship with Microsoft is a logical expansion of our service.๏ฟฝ About VeriChip Corporation VeriChip Corporation, headquartered in Delray Beach, Florida, markets its VeriMed๏ฟฝ Health Link System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, cleared for medical use in October 2004 by the United States Food and Drug Administration. For more information on VeriChip, please call 1-800-970-2447, or e-mail info@verichipcorp.com. Additional information can be found online at www.verichipcorp.com. Statements about VeriChip๏ฟฝs future expectations, including its ability to integrate its VeriMed Health Link system with Microsoft๏ฟฝs HealthVault, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and VeriChip๏ฟฝs actual results could differ materially from expected results. Additional information about these and other factors that could affect the Company๏ฟฝs business is set forth in the Company๏ฟฝs various filings with the Securities and Exchange Commission, including those set forth in the Company๏ฟฝs 10-K filed on March 28, 2008, as amended, under the caption ๏ฟฝRisk Factors.๏ฟฝ The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Verichip (MM) (NASDAQ:CHIP)
๊ณผ๊ฑฐ ๋ฐ์ดํ„ฐ ์ฃผ์‹ ์ฐจํŠธ
๋ถ€ํ„ฐ 6์›”(6) 2024 ์œผ๋กœ 7์›”(7) 2024 Verichip (MM) ์ฐจํŠธ๋ฅผ ๋” ๋ณด๋ ค๋ฉด ์—ฌ๊ธฐ๋ฅผ ํด๋ฆญ.
Verichip (MM) (NASDAQ:CHIP)
๊ณผ๊ฑฐ ๋ฐ์ดํ„ฐ ์ฃผ์‹ ์ฐจํŠธ
๋ถ€ํ„ฐ 7์›”(7) 2023 ์œผ๋กœ 7์›”(7) 2024 Verichip (MM) ์ฐจํŠธ๋ฅผ ๋” ๋ณด๋ ค๋ฉด ์—ฌ๊ธฐ๋ฅผ ํด๋ฆญ.